These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 17624291)

  • 1. Facile syntheses of [35S]homocysteine-thiolactone, [35S]homocystine, [35S]homocysteine, and [S-nitroso-35S]homocysteine.
    Jakubowski H
    Anal Biochem; 2007 Nov; 370(1):124-6. PubMed ID: 17624291
    [No Abstract]   [Full Text] [Related]  

  • 2. The preparation of [35S]homocysteine thiolactone free of [35S]methionine.
    Stern PH; Mecham JO; Hoffman RM
    J Biochem Biophys Methods; 1982 Dec; 7(1):83-8. PubMed ID: 7153460
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and radiobiological applications of [35S]L-homocysteine thiolactone.
    Grunbaum Z; Kroll K; Greene JL; Rasey JS; Krohn KA
    Int J Rad Appl Instrum B; 1990; 17(5):473-8. PubMed ID: 2391242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of homocysteine thiolactone, reduced homocysteine, homocystine, homocysteine-cysteine mixed disulfide, cysteine and cystine in a reaction mixture by overimposed pressure/voltage capillary electrophoresis.
    Zinellu A; Sotgia S; Scanu B; Pisanu E; Sanna M; Sati S; Deiana L; Sengupta S; Carru C
    Talanta; 2010 Sep; 82(4):1281-5. PubMed ID: 20801329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-Ribosylhomocysteine analogs containing a [4-thio]ribose ring.
    Sobczak AJ; Chbib C; Wnuk SF
    Carbohydr Res; 2015 Oct; 415():39-47. PubMed ID: 26279525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irreversible inhibition of lysyl oxidase by homocysteine thiolactone and its selenium and oxygen analogues. Implications for homocystinuria.
    Liu G; Nellaiappan K; Kagan HM
    J Biol Chem; 1997 Dec; 272(51):32370-7. PubMed ID: 9405445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies on homocysteine and its metabolite-homocysteine thiolactone action in blood platelets in vitro.
    Olas B; Kedzierska M; Wachowicz B
    Platelets; 2008 Nov; 19(7):520-7. PubMed ID: 18979364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of homocysteine toxicity in humans.
    Perła-Kaján J; Twardowski T; Jakubowski H
    Amino Acids; 2007; 32(4):561-72. PubMed ID: 17285228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine transport by human aortic endothelial cells: identification and properties of import systems.
    Büdy B; O'Neill R; DiBello PM; Sengupta S; Jacobsen DW
    Arch Biochem Biophys; 2006 Feb; 446(2):119-30. PubMed ID: 16455044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of S-alkyl L-homocysteine analogues of glutathione and their kinetic studies with gamma-glutamyl transpeptidase.
    Lherbet C; Gravel C; Keillor JW
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3451-5. PubMed ID: 15177451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of the condensation of homocysteine thiolactone with aldehydes.
    Jakubowski H
    Chemistry; 2006 Oct; 12(31):8039-43. PubMed ID: 16952131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acidic derivatives of homocysteine thiolactone: utility as anionic linkers.
    Leanza WJ; Chupak LS; Tolman RL; Marburg S
    Bioconjug Chem; 1992; 3(6):514-8. PubMed ID: 1463782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin activity is inhibited by acrolein and homocysteine thiolactone: Protection by cysteine.
    Gugliucci A
    Life Sci; 2008 Feb; 82(7-8):413-8. PubMed ID: 18206177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of L-homocysteine from L-homocysteine thiolactone.
    Uerre JA; Miller CH
    Anal Biochem; 1966 Nov; 17(2):310-5. PubMed ID: 5971425
    [No Abstract]   [Full Text] [Related]  

  • 15. The chemical synthesis of high specific-activity [35S]adenosylhomocysteine.
    Stern PH; Hoffman RM
    Anal Biochem; 1986 Nov; 158(2):408-12. PubMed ID: 3812981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.
    Jakubowski H
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():155-67. PubMed ID: 19261978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paper electrophoretic quantitation and measurement of the radioactivities of labelled sulphur amino acids as their oxidation derivatives.
    Huovinen JA
    Acta Chem Scand; 1966; 20(10):2678-82. PubMed ID: 5964487
    [No Abstract]   [Full Text] [Related]  

  • 18. Stable-isotope dilution LC-ESI-MS/MS techniques for the quantification of total homocysteine in human plasma.
    Tomaiuolo M; Vecchione G; Margaglione M; Pisanelli D; Grandone E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(28):3292-9. PubMed ID: 19651543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PATHOLOGY OF AMINO ACID EXCESS. I. EFFECTS OF ADMINISTRATION OF EXCESSIVE AMOUNTS OF SULPHUR CONTAINING AMINO ACIDS: HOMOCYSTINE.
    KLAVINS JV
    Br J Exp Pathol; 1963 Oct; 44(5):507-15. PubMed ID: 14066126
    [No Abstract]   [Full Text] [Related]  

  • 20. Homocystine levels, polymorphisms and the risk of ischemic stroke in young Asian Indians.
    Biswas A; Ranjan R; Meena A; Akhter MS; Yadav BK; Munisamy M; Subbiah V; Behari M; Saxena R
    J Stroke Cerebrovasc Dis; 2009; 18(2):103-10. PubMed ID: 19251185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.